FDA and FTC warned My Natural Treatment over COVID-19 claims for promoted essential oils.
What happened
FDA reviewed the website on January 18, 2022, and FTC reviewed it on February 11, 2022. The site and a Facebook page directed consumers to buy thyme, black seed, eucalyptus, rosemary, and peppermint oils through Amazon Associate links, while the site claimed these oils could prevent or treat COVID-19.
What FDA found
The website’s COVID-19 claims make the promoted essential oils unapproved new drugs.
FD&C Act §505(a), 21 U.S.C. §355(a)The same claims make the products misbranded drugs.
FD&C Act §502, 21 U.S.C. §352Causing these products to be introduced into interstate commerce is prohibited.
FD&C Act §§301(a) and (d), 21 U.S.C. §331(a) and (d)Doing acts to a drug held for sale after interstate shipment that result in misbranding is prohibited.
FD&C Act §301(k), 21 U.S.C. §331(k)FTC says the company lacks competent and reliable scientific evidence for disease-prevention or treatment claims.
FTC Act, 15 U.S.C. §41 et seq.FTC cites civil penalties for deceptive COVID-19 treatment, cure, prevention, or mitigation claims.
COVID-19 Consumer Protection Act §1401, Division FF, Consolidated Appropriations Act, 2021, P.L. 116-260
What FDA wants
FDA requests immediate action to stop sale of unapproved and unauthorized COVID-19 products and asks for an email within 48 hours describing corrective steps; FTC asks for a certification within 48 hours that unsubstantiated claims have ceased.
Who should pay attention
- affiliate marketers and influencers promoting health products
- brands whose products are promoted through affiliate links
- consumer health websites making disease claims
This is a summary. Read the original letter on fda.gov.